Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziming Du

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|July 29, 2021
Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resectionXiuxing Chen, Ziming Du, Mayan Huang, et al.
Cell Death & Disease|May 2, 2026
Hypermethylation of ZNF154 promotes malignant potential of ovarian cancer cells by diminishing ZNF154/KAP1-mediated ROMO1 repressionMingbiao Wei, Yuxia Xu, Ling Deng, et al.
Oncotarget|April 23, 2016
Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioningQin Li, Lalit Rane, Thomas Poiret, et al.
Neuro-Oncology|March 7, 2018
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngiomaShannon Coy, Rumana Rashid, Jia-Ren Lin, et al.
Cancer Genetics|May 13, 2015
ARID1A and TERT promoter mutations in dedifferentiated meningiomaMalak S Abedalthagafi, Wenya Linda Bi, Parker H Merrill, et al.
Oncotarget|September 23, 2016
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumorsYu Mei, Wenya Linda Bi, Noah F Greenwald, et al.
Frontiers in Immunology|January 2, 2023
Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastasesMingtao Hu, Zhigang Chen, Dandan Hu, et al.
Clinical and Translational Medicine|September 23, 2023
Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cellsJiaojiao Yang, Liyue Sun, Xiao-Yun Liu, et al.
Oncotarget|January 23, 2015
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaZiming Du, Malak Abedalthagafi, Ayal A Aizer, et al.
NPJ Breast Cancer|January 3, 2024
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancerJennifer L Guerriero, Jia-Ren Lin, Ricardo G Pastorello, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|July 29, 2021
Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resectionXiuxing Chen, Ziming Du, Mayan Huang, et al.
Cell Death & Disease|May 2, 2026
Hypermethylation of ZNF154 promotes malignant potential of ovarian cancer cells by diminishing ZNF154/KAP1-mediated ROMO1 repressionMingbiao Wei, Yuxia Xu, Ling Deng, et al.
Oncotarget|April 23, 2016
Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioningQin Li, Lalit Rane, Thomas Poiret, et al.
Neuro-Oncology|March 7, 2018
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngiomaShannon Coy, Rumana Rashid, Jia-Ren Lin, et al.
Cancer Genetics|May 13, 2015
ARID1A and TERT promoter mutations in dedifferentiated meningiomaMalak S Abedalthagafi, Wenya Linda Bi, Parker H Merrill, et al.
Oncotarget|September 23, 2016
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumorsYu Mei, Wenya Linda Bi, Noah F Greenwald, et al.
Frontiers in Immunology|January 2, 2023
Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastasesMingtao Hu, Zhigang Chen, Dandan Hu, et al.
Clinical and Translational Medicine|September 23, 2023
Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cellsJiaojiao Yang, Liyue Sun, Xiao-Yun Liu, et al.
Oncotarget|January 23, 2015
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaZiming Du, Malak Abedalthagafi, Ayal A Aizer, et al.
NPJ Breast Cancer|January 3, 2024
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancerJennifer L Guerriero, Jia-Ren Lin, Ricardo G Pastorello, et al.
Pageof 3